Winston & Strawn

Site Search

Professionals (127)
Capabilities (49)
Experience (20)
Insights & News (1,182)
Other Results (66)

Professionals 127 results

Sandy Pleckaitis

Director

Chicago

+1 312-558-3185

vCard

Director

Chicago

Abigail Clarke-Sayer

Director

New York

+1 212-294-4729

vCard

Director

New York

J. Eric Johnson

Partner

Houston

+1 713-651-2647

vCard

Partner

Houston

View All Professionals

Capabilities 49 results

Practice Area

Employee Benefits & Executive Compensation

With attorneys based in Chicago, New York and Washington, D.C., Winston’s Employee Benefits & Executive Compensation (EBEC) team represents a broad range of plan sponsors and offers clients not just deal support but the full suite of employee benefit services. These include public company reporting and executive compensation, employee benefits in mergers and acquisitions, qualified retirement plans and Title I investment advice, health and welfare benefit plans, employee stock ownership plans (ESOPs), and international human resources matters. And driven by a volatile labor market, we are partnering with clients to innovate plan structure and design, including cutting-edge services such as private exchange medical benefits, employee benefits in captive insurance, and fiduciary governance best practices. With decades of experience, our EBEC team maintains strong brand recognition, with clients describing our attorneys as “superb,” “very client-friendly,” “extremely responsive and able to bring forth the right resources,” and “having an “incredible breadth of knowledge.”...Read more

Practice Area

Environmental Litigation & Enforcement

With today’s rapidly evolving rules of engagement, paired with the often contentious nature of environmental disputes, clients rely on Winston for our practical experience and substantive knowledge of the broad-ranging issues involved in environmental litigation, enforcement, and investigations....Read more

Region

Latin America & Caribbean

Winston’s deep experience representing companies and investors across Latin America and the Caribbean has made the firm a “go-to” resource for the strategic development of our clients’ businesses and the vigorous protection of their interests in the region. With broad command of a diverse range of issues within the region’s key industry sectors, we advise Fortune 500 companies, government and quasi-governmental entities, financial institutions, private equity and other investors, domestic and international oil and gas exploration and production companies, refiners and shippers, and a range of commercial and infrastructure developers....Read more

Experience 20 results

Experience

March 25, 2026

Winston Represented Greenland Energy Exploration Limited in Business Combination with Pelican Acquisition Corporation, March GL Company, and Pelican Holdco, Inc.

Winston served as counsel to Greenland Exploration Limited in connection with its business combination with Pelican Acquisition Corporation, March GL Company, and Pelican Holdco, Inc., resulting in the formation of Greenland Energy Company, a publicly traded energy platform. The transaction positions Greenland Energy as a platform focused on enhancing global energy security through the responsible development of natural resources in East Greenland, including the highly prospective Jameson Land Basin, which spans over 2 million acres and is estimated to contain up to 13 billion barrels of recoverable oil....Read more

Experience

January 22, 2026

Advised SQM on US$600M offering of subordinated capital notes due 2056 (Hybrid Bond Offering)

Winston & Strawn LLP advised longstanding client Sociedad Química y Minera de Chile S.A. (“SQM”) (NYSE: SQM) on its US$600 million offering of subordinated capital notes. The notes were offered in the United States pursuant to Rule 144A and outside the United States pursuant to Regulation S.The subordinated capital notes are due in 2056 and constitute SQM’s first international hybrid bond issuance, structured to be consistent with SQM’s recent UF 10 million (approximately US$ 430 million) Series S hybrid-subordinated bond issuance in the Chilean securities market. The notes bear an initial annual interest rate of 5.625% and are subject to reset on April 22, 2031 (the “First Reset Date”), and on every fifth anniversary thereafter, based on a spread over the 5-year U.S. Treasury bond rate, with interest rate step-ups on the fifth and twentieth anniversaries of the First Reset Date. The transaction closed on January 22, 2026.BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Santander US Capital Markets LLC, and Scotia Capital (USA) Inc. acted as initial purchasers of the notes.Link Capital Partners was financial advisor to SQM.SQM is a global company with a leading position in the lithium, iodine, and potassium nitrate markets. It develops and produces a diverse range of products for industries essential to human progress, including health, nutrition, renewable energy, and technology, driven by innovation and technological development.The Winston & Strawn team advising on the transaction included corporate partner Sey-Hyo Lee (New York) and foreign legal advisor Bruno M. Fiorino (New York). Partner Katherine Erbeznik (New York) advised on tax matters....Read more

Experience

July 17, 2025

D. Boral Capital Closes US$15M Robot Consulting IPO

Winston & Strawn LLP represented D. Boral Capital LLC and Craft Capital Management LLC in connection with the US$15M initial public offering of American Depositary Shares (ADSs) of Robot Consulting Co., Ltd. The offering consisted of 3,750,000 ADSs priced at $4.00 per ADS, and the company’s ADSs began trading on the Nasdaq Capital Market under the ticker symbol “LAWR” on July 17, 2025....Read more

View All Experience

Insights & News 1,182 results

False Claims Act Playbook

May 14, 2026

3 Min Read

DOJ Launches FOCUS Initiative, Signaling Increasingly Data-Driven Era of FCA Enforcement

On April 30, 2026, the U.S. Department of Justice’s Civil Division announced a new initiative called the Fraud Oversight through Careful Use of Statistics (“FOCUS”) initiative, aimed at strengthening DOJ’s engagement with so‑called “data miner” whistleblowers who bring False Claims Act (FCA) qui tam actions based on publicly available government data, rather than insider knowledge.

Competition Corner

April 29, 2026

10+ Min Read

The Tunney Act Under the Spotlight: Recent Settlements Reignite Calls for Reform of Antitrust Oversight

Recent settlements in DOJ antitrust enforcement actions have raised concerns on Capitol Hill and beyond about the adequacy of current safeguards governing the settlement of federal antitrust cases.

Product Liability & Mass Torts Digest

April 3, 2026

8 Min Read

A Recipe for Exclusion: Why the Baby Food MDL Experts Failed Under Daubert

In a high-stakes decision on expert exclusion authored late last month, the District Court for the Northern District of California granted defendants’ motion to exclude plaintiffs’ general causation expert witnesses in In re Baby Food Products Liability Litigation—a consolidated mass tort of over 100 pending cases regarding the alleged presence of toxic heavy metals in baby food.

View All Insights & News

Other Results 66 results

Site Content

Links to External AI Resources

Below are links to third-party AI resources....Read more

Site Content

What Is a Biosimilar?

A subset of biologics, a biosimilar is a biologic that is highly similar to an FDA-approved product, referred to as the reference product. Biosimilars have no clinically meaningful differences compared to a reference product in terms of safety, purity, and potency as demonstrated through human pharmacokinetic and pharmacodynamics studies. Because of their complexity, biosimilars are unlikely to be identical replicates of their comparable reference products....Read more

Site Content

What Is Epidemiology?

In the product liability context, epidemiology refers to the study of the incidence, distribution, and etiology of disease or harm in human populations. Epidemiological studies include a variety of different study designs, such as prospective and retrospective cohort studies, case-control studies, randomized controlled trials, and meta-analysis. Epidemiology is a critical, and sometimes mandatory, element for establishing general causation....Read more